| Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer (NCT03520842) | Stanford University | 2018-08-14 |
| Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads (NCT03023904) | Vanderbilt-Ingram Cancer Center | 2017-12-29 |
| Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer (NCT03121417) | Emory University | 2017-07-21 |
| Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT03048500) | Northwestern University | 2017-07-12 |
| Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT02947386) | Roswell Park Cancer Institute | 2017-06-29 |
| Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer (NCT02846792) | University of Washington | 2017-06-14 |
| Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer (NCT03137771) | NRG Oncology | 2017-04-07 |
| Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations (NCT02949843) | Wake Forest University Health Sciences | 2017-03-10 |
| Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 (NCT03049618) | University of Southern California | 2017-03-10 |
| TG4010 and Nivolumab in Patients With Lung Cancer (NCT02823990) | Megan Daly, MD | 2016-12-14 |
| Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02581943) | Wake Forest University Health Sciences | 2016-06-17 |
| Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer (NCT02451865) | Jonsson Comprehensive Cancer Center | 2016-06-01 |
| Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography (NCT02819024) | Barbara Ann Karmanos Cancer Institute | 2016-06-01 |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors (NCT02650635) | Mayo Clinic | 2016-02-05 |
| MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer (NCT02400814) | Megan Daly, MD | 2015-12-03 |
| Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib (NCT02364609) | Jonathan Riess | 2015-09-30 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
| S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer (NCT02438722) | SWOG Cancer Research Network | 2015-05-07 |
| Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT02009436) | Albert Einstein College of Medicine | 2015-02-09 |
| Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer (NCT02186847) | NRG Oncology | 2014-08-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer (NCT02206334) | NRG Oncology | 2014-08-01 |
| Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection (NCT02134886) | National Cancer Institute (NCI) | 2014-07-01 |
| Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer (NCT01737502) | Mayo Clinic | 2014-05-14 |
| Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery (NCT01854684) | Roswell Park Cancer Institute | 2014-02-21 |
| PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer (NCT02073968) | Albert Einstein College of Medicine | 2013-07-01 |
| Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT01935947) | National Cancer Institute (NCI) | 2013-05-01 |
| Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer (NCT01727076) | National Cancer Institute (NCI) | 2013-02-15 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer (NCT01620190) | University of Washington | 2012-12-02 |
| Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment (NCT02895503) | Virginia Commonwealth University | 2012-01-01 |
| MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy (NCT01294306) | National Cancer Institute (NCI) | 2011-02-01 |
| RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT01193881) | National Cancer Institute (NCI) | 2010-08-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT00955305) | National Cancer Institute (NCI) | 2010-03-01 |
| A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC (NCT00963807) | National Cancer Institute (NCI) | 2009-09-01 |
| Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00738881) | National Cancer Institute (NCI) | 2008-10-01 |
| Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer (NCT00698815) | National Cancer Institute (NCI) | 2008-04-15 |
| Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer (NCT00602797) | University of Nebraska | 2007-12-17 |
| Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer (NCT00387465) | National Cancer Institute (NCI) | 2006-08-01 |
| Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer (NCT00950365) | Albert Einstein College of Medicine | 2006-04-01 |
| Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer (NCT00096265) | National Cancer Institute (NCI) | 2004-10-06 |